Emerging aspects of rabies infection: With a special emphasis on children

Current Opinion in Infectious Diseases

Volumn 21, Issue 3, 2008, Pages 251-257

  Warrell, Mary J ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

Cerebral malaria; Lyssavirus; Rabies; Recovery

Indexed keywords

ALPHA INTERFERON; AMANTADINE; KETAMINE; RABIES IMMUNOGLOBULIN; RABIES VACCINE; RIBAVIRIN;

DRUG ACTIVITY; ENCEPHALITIS; GENOTYPE; HISTOPATHOLOGY; HUMAN; INFECTION RISK; MORTALITY; NONHUMAN; PATHOGENESIS; PROPHYLAXIS; RABIES; RABIES VIRUS; REVIEW; SURVIVAL RATE; UNITED KINGDOM; VACCINATION; VIRUS REPLICATION;

ANIMALS; CHILD; CHILD, PRESCHOOL; CHIROPTERA; DIAGNOSIS, DIFFERENTIAL; DOGS; ENCEPHALITIS, VIRAL; HUMANS; IMMUNOGLOBULINS; LYSSAVIRUS; MALARIA, CEREBRAL; RABIES; RABIES VACCINES; RHABDOVIRIDAE INFECTIONS;

EID: 42949121555     PISSN: 09517375     EISSN: None     Source Type: Journal    
DOI: 10.1097/QCO.0b013e3282fc705b     Document Type: Review

References (68)

1. Rabies has its day. Lancet Infect Dis 2007; 7:631.
2. Nel LH, Markotter W. Lyssaviruses. Crit Rev Microbiol 2007; 33:301-324. An authoritative, comprehensive compilation of the lyssaviruses from all continents and their distribution.
3. Knobel DL, Cleaveland S, Coleman PG, et al. Re-evaluating the burden of rabies in Africa and Asia. Bull World Health Organ 2005; 83:360-368.
4. Buyuk Y, Uzun I, Aybar Y, et al. Rabies in Turkey: three human cases illustrating the importance of suspecting exposure. Wilderness Environ Med 2007; 18:214-217.
5. van Thiel PPAM, van den Hoek JAR, Eftimov F, et al. Fatal case of human rabies (Duvenhage virus) from a bat in Kenya: the Netherlands, December 2007. Euro Surveill [available online] 2008; 13. http://www.eurosurveillance. org/edition/v13n02/080110_01.asp. [Accessed 25 January 2008] A preliminary case report of imported encephalitis caused by a rabies-related lyssavirus not known to be present in East Africa. We await the details.
6. Diop SA, Manga NM, Dia NM, et al. The point on human rabies in Sénégal from 1986 to 2005. Med Mal Infect 2007; 37:787-791.
7. Cohen C, Sartorious B, Sabeta C, et al. Epidemiology and molecular virus characterization of reemerging rabies, South Africa. Emerg Infect Dis 2007; 12:1879-1886. A thorough investigation of a canine rabies outbreak with retrospective detection of unrecognized human cases.
8. Mallewa M, Fooks AR, Banda D, et al. Rabies encephalitis in malaria-endemic area, Malawi, Africa. Emerg Infect Dis 2007; 13:136-139. A rare attempt to diagnose paediatric neurological diseases, showing the value of postmortem tests. The lack of routine laboratory facilities prevents progress in prevention.
9. Rabies Bull Euro. Rabies infections in organ donor and transplant recipients in Germany (2005). 2005; 3:8-9. http://www.who-rabies-bulletin.org/ Journal/Miscellaneous_Articles.aspx?Issue=2005_3. [Accessed 25 January 2008).
10. Srinivasan A, Burton EC, Kuehnert MJ, et al. Transmission of rabies virus from an organ donor to four transplant recipients. N Engl J Med 2005; 352:1103-1111.
11. Burton EC, Burns DK, Opatowsky MJ, et al. Rabies encephalomyelitis: clinical, neuroradiological, and pathological findings in 4 transplant recipients. Arch Neurol 2005; 62:873-882.
12. Pfukenyi DM, Pawandiwa D, Makaya PV, Ushewokunze-Obatolu U. A retrospective study of rabies in humans in Zimbabwe, between 1992 and 2003. Acta Trop 2007; 102:190-196. A welcome contribution to the small amount of data on human rabies in Africa.
13. Sudarshan MK, Mahendra BJ, Madhusudana SN, et al. An epidemiological study of animal bites in India: results of a WHO sponsored national multicentric rabies survey. J Commun Dis 2006; 38:32-39.
14. Sriaroon C, Sriaroon P, Daviratanasilpa S, et al. Retrospective: animal attacks and rabies exposures in Thai children. Travel Med Infect Dis 2006; 4:270-274.
15. Gautret P, Schwartz E, Shaw M, et al. Animal-associated injuries and related diseases among returned travellers: a review of the GeoSentinel surveillance network. Vaccine 2007; 25:2656-2663.
16. Hampson K, Dushoff J, Bingham J, et al. Synchronous cycles of domestic dog rabies in sub-Saharan Africa and the impact of control efforts. Proc Natl Acad Sci U S A 2007; 104:7717-7722. Evidence that lapses in dog vaccination leads to rabies epidemics.
17. Nel LH, Rupprecht CE. Emergence of lyssaviruses in the Old World: the case of Africa. Curr Top Microbiol Immunol 2007; 315:161-193. Epidemiological, historical and genetic details of all the African lyssaviruses.
18. Nathwani D, McIntyre PG, White K, et al. Fatal human rabies caused by European bat Lyssavirus type 2a infection in Scotland. Clin Infect Dis 2003; 37:598-601.
19. Fooks AR, Marston D, Parsons G, et al. Isolation of EBLV-2 in a Daubenton's bat (Myotis daubentonii) found in Oxfordshire. Vet Rec 2006; 159:534-535.
20. Duggal H. European bat lyssavirus type 2: human exposure in England. Euro Surveill 2007; 12:E070906.5.
21. Amengual B, Bourhy H, Lopez-Roig M, Serra-Cobo J. Temporal dynamics of European bat Lyssavirus type 1 and survival of Myotis myotis bats in natural colonies. PLoS ONE 2007; 2:e566.
22. McColl KA, Chamberlain T, Lunt RA, et al. Susceptibility of domestic dogs and cats to Australian bat lyssavirus (ABLV). Vet Microbiol 2007; 123:15-25. This experiment explains why ABLV has not been transmitted by dogs and cats.
23. Vos A, Muller T, Neubert L, et al. Rabies in red foxes (Vulpes vulpes) experimentally infected with European bat lyssavirus type 1. J Vet Med B Infect Dis Vet Public Health 2004; 51:327-332.
24. Tjornehoj K, Fooks AR, Agerholm JS, Ronsholt L. Natural and experimental infection of sheep with European bat lyssavirus type-1 of Danish bat origin. J Comp Pathol 2006; 134:190-201.
25. Warrell MJ. Rabies and other lyssavirus infections. In: Zuckerman AJ, Banatvala JE, Griffiths PD, Mortimer PP, Schoub BD, editors. Principles & practice of clinical virology, 6th ed. Chichester: John Wiley & Sons. (in press). Further reading and references on all topics in this review.
26. Lafon M. Modulation of the immune response in the nervous system by rabies virus. Curr Top Microbiol Immunol 2005; 289:239-258.
27. Jackson AC. Pathogenisis. In: Jackson AC, Wunner AH, editors. Rabies, Second ed. London: Elsevier, Academic Press; 2007. pp. 341-381. A critical evaluation of research into rabies pathogenesis.
28. Roy A, Phares TW, Koprowski H, Hooper DC. Failure to open the blood-brain barrier and deliver immune effectors to central nervous system tissues leads to the lethal outcome of silver-haired bat rabies virus infection. J Virol 2007; 81:1110-1118.
29. Roy A, Hooper DC. Lethal silver-haired bat rabies virus infection can be prevented by opening the blood-brain barrier. J Virol 2007; 81:7993-7998.
30. Phares TW, Fabis MJ, Brimer CM, et al. A peroxynitrite-dependent pathway is responsible for blood-brain barrier permeability changes during a central nervous system inflammatory response: TNF-alpha is neither necessary nor sufficient. J Immunol 2007; 178:7334-7343. Suggests that IFN-γ activity might promote rabies viral clearance from the brain.
31. Scott CA, Rossiter JP, Andrew RD, Jackson AC. Structural abnormalities in neurons are sufficient to explain the clinical disease and fatal outcome of experimental rabies in yellow fluorescent protein-expressing transgenic mice. J Virol 2008; 82:513-521. This renewed interest in electron microscopy, now combined with molecular genetics could be productive in the future.
32. Dhingra V, Li X, Liu Y, Fu ZF. Proteomic profiling reveals that rabies virus infection results in differential expression of host proteins involved in ion homeostasis and synaptic physiology in the central nervous system. J Neurovirol 2007; 13:107-117.
33. Finke S, Conzelmann KK. Replication strategies of rabies virus. Virus Res 2005; 111:120-131.
34. Klingen Y, Conzelmann KK, Finke S. Double-labeled rabies virus: live tracking of enveloped virus transport. J Virol 2008; 82:237-245. The intraneural movement of rabies virus in live cells, described here, offers great opportunity for investigating the molecules involved.
35. Tuffereau C, Schmidt K, Langevin C, et al. The rabies virus glycoprotein receptor p75NTR is not essential for rabies virus infection. J Virol 2007; 81:13622-13630.
36. Tan GS, Preuss MA, Williams JC, Schnell MJ. The dynein light chain 8 binding motif of rabies virus phosphoprotein promotes efficient viral transcription. Proc Natl Acad Sci U S A 2007; 104:7229-7234.
37. Ugolini G, Klam F, Doldan Dans M, et al. Horizontal eye movement networks in primates as revealed by retrograde transneuronal transfer of rabies virus: differences in monosynaptic input to "slow" and "fast" abducens motoneurons. J Comp Neurol 2006; 498:762-785.
38. Hattwick MA, Weis TT, Stechschulte CJ, et al. Recovery from rabies. A case report. Ann Intern Med 1972; 76:931-942.
39. Jackson AC. Human disease. In: Jackson AC, Wunner AH, editors. Rabies, Second ed. London: Elsevier, Academic Press; 2007. pp. 309-340. A reliable detailed review of the literature.
40. Willoughby RE Jr, Tieves KS, Hoffman GM, et al. Survival after treatment of rabies with induction of coma. N Engl J Med 2005; 352:2508-2514.
41. Hu WT, Willoughby RE Jr, Dhonau H, Mack KJ. Long-term follow-up after treatment of rabies by induction of coma. N Engl J Med 2007; 357:945-946.
42. Jackson AC, Warrell MJ, Rupprecht CE, et al. Management of rabies in humans. Clin Infect Dis 2003; 36:60-63.
43. Jackson AC, Scott CA, Owen J, et al. Therapy with minocycline aggravates experimental rabies in mice. J Virol 2007; 81:6248-6253.
44. Hooper DC. The role of immune responses in the pathogenesis of rabies. J Neurovirol 2005; 11:88-92.
45. Yan X, Prosniak M, Curtis MT, et al. Silver-haired bat rabies virus variant does not induce apoptosis in the brain of experimentally infected mice. J Neurovirol 2001; 7:518-527.
46. Prosniak M, Zborek A, Scott GS, et al. Differential expression of growth factors at the cellular level in virus-infected brain. Proc Natl Acad Sci U S A 2003; 100:6765-6770.
47. Centre for disease control and Prevention. Human rabies-Indiana and California, 2006. MMWR Morb Mortal Wkly Rep 2007; 56:361-365. Two patients, one infected with American bat virus and the other by a dog virus in the Philippines, were treated unsuccessfully with intensive care in the USA.
48. Hemachudha T, Sunsaneewitayakul B, Desudchit T, et al. Failure of therapeutic coma and ketamine for therapy of human rabies. J Neurovirol 2006; 12:407-409.
49. Schmiedel S, Panning M, Lohse A, et al. Case report on fatal human rabies infection in Hamburg, Germany, March 2007. Euro Surveill [available from] 2007; 12:E070531.5.: http://www.eurosurveillance.org/ew/2007/070531.asp#5. [Accessed 25January 2008].
50. Hooper DC, Morimoto K, Bette M, et al. Collaboration of antibody and inflammation in clearance of rabies virus from the central nervous system. J Virol 1998; 72:3711-3719.
51. Consales CA, Mendonca RZ, Lucchiari MA, et al. Macrophage activity in rabies virus infection of genetically selected high and low antibody responder lines of mice. Res Virol 1990; 141:57-67.
52. Rabies vaccines. WHO position paper. Wkly Epidemiol Rec [available online] 2007; 82:425-435. http://www.who.int/wer/2007/wer8249_50.pdf. [Accessed 28January 2008] An accessible updated summary of the latest recommendations on human prophylaxis.
53. Reece JF. Rabies in India: an ABC approach to combating the disease in street dogs. Vet Rec 2007; 161:292-293. A summary of recent work showing that control of urban dog rabies reduces the incidence of human cases.
54. Servat A, Feyssaguet M, Blanchard I, et al. A quantitative indirect ELISA to monitor the effectiveness of rabies vaccination in domestic and wild carnivores. J Immunol Methods 2007; 318:1-10.
55. Feyssaguet M, Dacheux L, Audry L, et al. Multicenter comparative study of a new ELISA, PLATELIA RABIES II, for the detection and titration of antirabies glycoprotein antibodies and comparison with the rapid fluorescent focus inhibition test (RFFIT) on human samples from vaccinated and nonvaccinated people. Vaccine 2007; 25:2244-2251. Despite experiments over 30 years, ELISA tests have failed to give reliable results equivalent to the rabies neutralizing antibody which gives the best available correlation with protection. This new method is promising, but the commercial kits are expensive.
56. WHO (1997). WHO recommendations on rabies postexposure treatment and the correct technique of intradermal immunization against rabies. WHO/EMC/ZOO.96.6. http://whqlibdoc.who.int/hq/1996/WHO_EMC_ZOO_96.6.pdf. [Accessed 25 January 2008]
57. Paweska JT, Blumberg LH, Liebenberg C, et al. Fatal human infection with rabies-related Duvenhage virus, South Africa. Emerg Infect Dis 2006; 12:1965-1967.
58. Sloan SE, Hanlon C, Weldon W, et al. Identification and characterization of a human monoclonal antibody that potently neutralizes a broad panel of rabies virus isolates. Vaccine 2007; 25:2800-2810.
59. de Kruif J, Bakker AB, Marissen WE, et al. A human monoclonal antibody cocktail as a novel component of rabies postexposure prophylaxis. Annu Rev Med 2007; 58:359-368.
60. Nagarajan T, Rupprecht CE, Dessain SK, et al. Human monoclonal antibody and vaccine approaches to prevent human rabies. Curr Top Microbiol Immunol 2008; 317:67-101. This review describes current human prophylaxis in India, and indigenous research on a monoclonal alternative to RIG.
61. Dobardzic A, Izurieta H, Woo EJ, et al. Safety review of the purified chick embryo cell rabies vaccine: Data from the vaccine adverse event reporting system (VAERS), 1997-2005. Vaccine 2007; 25:4244-4251.
62. Toovey S. Preventing rabies with the Verorab vaccine: 1985-2005 Twenty years of clinical experience. Travel Med Infect Dis 2007; 5:327-348.
63. Suwansrinon K, Jaijareonsup W, Wilde H, et al. Sex- and age-related differences in rabies immunoglobulin hypersensitivity. Trans R Soc Trop Med Hyg 2007; 101:206-208. Reactions to human and equine RIG are usually local effects and very low rates were found among more than 70 000 patients.
64. Meslin FX. Rabies as a traveler's risk, especially in high-endemicity areas. J Travel Med 2005; 12 (Suppl 1):S30-S40.
65. Vien NC, Feroldi E, Lang J. Long-term antirabies antibody persistence following intramuscular or low-dose intradermal vaccination of young Vietnamese children. Trans R Soc Trop Med Hyg 2008; 102:294-296. This well conducted study shows no interference of rabies vaccine on the immunogenicity of the routine childhood vaccines given concomitantly.
66. Dodet B. An important date in rabies history. Vaccine 2007; 25:8647-8650.
67. Harish R. Rabies vaccine: a case for optional childhood vaccination. Indian Pediatr 2007; 44:792-793.
68. Warrell MJ, Riddell A, Yu L-M, et al. A simplified 4-site economical intradermal post-exposure rabies vaccine regimen: a randomised controlled comparison with standard methods. PLoS Negl Trop Dis 2008; 2(4): e224. doi:10.1371/journal.pntd.0000224.